A Phase 1b, Randomized, Double-Blind, Placebo Controlled Study With an Open Label Extension to Evaluate the Safety and Tolerability of Omalizumab, A Humanized IgG1 Monoclonal Antibody in Patients With Lupus (STOP LUPUS) A Phase 1b, Randomized, Double-Blind, Placebo Controlled Study With an Open Label Extension to Evalu ...